-
Active Stocks: Mast Therapeutics (NYSEMKT:MSTX), KeyCorp. (NYSE:KEY), Fomento Economico Mexicano SAB (ADR) (NYSE:FMX), Leidos Holdings (NYSE:LDOS), China Pharma Holdings (NYSEMKT:CPHI)
Mast Therapeutics, Inc. (NYSEMKT:MSTX) in last trading activity moved down -0.98% to close at $0.50. Company weekly performance is -8.18% while its quarterly performance stands at 14.77%. Mast Therapeutics, Inc. (NYSEMKT:MSTX) is -30.82% away from its 52 week high. Mast Therapeutics, Inc. (NYSEMKT:MSTX), reported financial results for the quarter ended March 31, 2015. The Company’s…
-
Worth Watching Stocks: Charles & Colvard (NASDAQ:CTHR), Titan International Inc. (NYSE:TWI), T-Mobile US (NYSE:TMUS), Mast Therapeutics (NYSEMKT:MSTX), Caterpillar (NYSE:CAT)
On Friday shares of Charles & Colvard Ltd. (NASDAQ:CTHR) closed at $1.55. Company’s sales growth for last 5 years was 25.30% and EPS growth for next 5 years is recorded as 30.00%. Zacks lowered shares of Charles & Colvard Ltd. (NASDAQ:CTHR) from a hold rating to a sell rating in a report released on Friday.…
-
Why Need to Watch: Itau Unibanco Holding SA (ADR) (NYSE:ITUB), Cytokinetics, Incorporated (NASDAQ:CYTK), Mast Therapeutics (NYSEMKT:MSTX), Heidrick & Struggles International (NASDAQ:HSII)
On Monday shares of Itau Unibanco Holding SA (ADR) (NYSE:ITUB) closed at $13.08. Company’s sales growth for last 5 years was 10.60% and EPS growth for next 5 years is recorded as 12.10%. Stock analysts at JPMorgan Chase & Co. cut their target price on shares of Itau Unibanco Holding SA (NASDAQ:ITUB) from $14.00 to…
-
Stocks in Focus: Mast Therapeutics (NYSEMKT:MSTX), Uranium Energy (NYSEMKT:UEC), Penns Woods Bancorp Inc. (NASDAQ:PWOD), Huttig Building Products Inc. (NASDAQ:HBP), LKQ Corp. (NASDAQ:LKQ)
On Monday shares of Mast Therapeutics, Inc. (NYSEMKT:MSTX) closed at $0.48. On 21 April, Mast Therapeutics, Inc. (NYSE:MSTX) reported that patient enrollment in its pivotal EPIC study of its lead product candidate, vepoloxamer (MST-188), in sickle cell disease has surpassed the halfway point. Consistent with prior guidance, the Company anticipates reporting top-line results in the…
-
Trending Tickers: Biostar Pharmaceuticals (NASDAQ:BSPM), Mast Therapeutics (NYSEMKT:MSTX), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), HCA Holdings (NYSE:HCA)
On Thursday shares of Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) closed at $1.50. Company’s sales growth for last 5 years was 9.20%. On 15 April, Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) announced its results of operations for the full year and the quarter ended December 31, 2014. – Net sales increased by $8.7 million, or 16.5%, year over year,…
-
Active Watch List: Mast Therapeutics (NYSEMKT:MSTX), The Joint Corp. (NASDAQ:JYNT), Twitter Inc (NYSE:TWTR), China Life Insurance (NYSE:LFC), Tupperware Brands (NYSE:TUP)
On Thursday shares of Mast Therapeutics, Inc. (NYSEMKT:MSTX) closed at $0.49. Mast Therapeutics, Inc. (NYSE: MSTX) announced that its lead compound (vepoloxamer) was shown in a nonclinical study to result in dose-dependent and statistically significant reductions in the adhesive properties and fragility of red blood cells from patients with sickle cell disease. The Joint Corp.…
-
Morning Alert: Groupon (NASDAQ:GRPN), Mast Therapeutics (NYSEMKT:MSTX), Cara Therapeutics Inc. (NASDAQ:CARA), Gilead Sciences Inc. (NASDAQ:GILD), AT&T (NYSE:T)
On Thursday shares of Groupon, Inc. (NASDAQ:GRPN) closed at $7.06. Company’s sales growth for last 5 years was 194.10% and EPS growth for next 5 years is recorded as 27.50%. Groupon Inc. (NASDAQ:GRPN) has left a mark on our digital markets. The popular retail service offered millions of businesses a response to incentivize customers to…
-
Today’s Hot List: Mast Therapeutics (NYSEMKT:MSTX), Pembina Pipeline Corporation (NYSE:PBA), Micron Technology (NASDAQ:MU), First Financial Bankshares (NASDAQ:FFIN), Columbia Sportswear (NASDAQ:COLM)
On Wednesday shares of Mast Therapeutics, Inc. (NYSEMKT:MSTX) closed at $0.46.On March 24, Mast Therapeutics, Inc. (NYSEMKT:MSTX), reported financial results for the fourth quarter and year ended December 31, 2014. The Company’s net loss for the fourth quarter of 2014 was $7.3 million, or $0.05 per share (basic and diluted), compared to a net loss…
-
Morning Watch List: Mast Therapeutics (NYSEMKT:MSTX), JinkoSolar (NYSE:JKS), Huron Consulting Group Inc. (NASDAQ:HURN), The Royal Bank of Scotland (NYSE:RBS), Axcelis Technologies (NASDAQ:ACLS)
On Friday shares of Mast Therapeutics, Inc. (NYSEMKT:MSTX) closed at $0.50. On March 24, Mast Therapeutics, Inc. (NYSEMKT:MSTX) reported financial results for the fourth quarter and year ended December 31, 2014. The Company’s net loss for the year ended December 31, 2014 was $28.7 million, or $0.23 per share (basic and diluted), compared to a…
-
Top Movers: Mast Therapeutics (NYSEMKT:MSTX), Medtronic plc (NYSE:MDT), MKS Instruments (NASDAQ:MKSI), Pacific Ethanol (NASDAQ:PEIX), Endologix Inc. (NASDAQ:ELGX)
On March 2, Mast Therapeutics, Inc. (NYSEMKT:MSTX) announced preliminary findings from a randomized, placebo-controlled, nonclinical study of vepoloxamer (MST-188) in a model of chronic, stable heart failure produced by intracoronary microembolizations. The primary objective of this study was to examine the effects of repeat intravenous administration of vepoloxamer on left ventricular (LV) systolic and diastolic…